MMP2 and cancer: As a consequence, looking at the somatic mutations of its composing genes (of which only Matrix Metallopeptidase 2 - MMP2 - has been reported as harbouring cancer-driving alterations in LUAD36) might reveal novel key components of this pathway leading to metastatic transitions.